Cyanobacteria Scytonema javanicum and Scytonema ocellatum Lipopolysaccharides Elicit Release of Superoxide Anion, Matrix-Metalloproteinase-9, Cytokines and Chemokines by Rat Microglia In Vitro
暂无分享,去创建一个
[1] A. Mayer,et al. Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[2] W. Banks,et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit , 2015, Journal of Neuroinflammation.
[3] S. Wood,et al. Changes in saxitoxin-production through growth phases in the metaphytic cyanobacterium Scytonema cf. crispum. , 2015, Toxicon : official journal of the International Society on Toxinology.
[4] R. Franco,et al. Alternatively activated microglia and macrophages in the central nervous system , 2015, Progress in Neurobiology.
[5] Sangdun Choi,et al. Structure and Effects of Cyanobacterial Lipopolysaccharides , 2015, Marine drugs.
[6] W. V. van Gool,et al. Systemic inflammation and microglial activation: systematic review of animal experiments , 2015, Journal of Neuroinflammation.
[7] S. Tajima,et al. Inflammatory responses and potencies of various lipopolysaccharides from bacteria and cyanobacteria in aquatic environments and water supply systems. , 2015, Toxicon : official journal of the International Society on Toxinology.
[8] N. Chen,et al. Selective modulation of microglia polarization to M2 phenotype for stroke treatment. , 2015, International immunopharmacology.
[9] R. Berisio,et al. Chemistry of lipid A: at the heart of innate immunity. , 2015, Chemistry.
[10] T. Boopathi,et al. Impact of Environmental Factors on the Regulation of Cyanotoxin Production , 2014, Toxins.
[11] M. O’Banion,et al. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed , 2014, Journal of Neuroinflammation.
[12] Sangdun Choi,et al. Gram-Negative Marine Bacteria: Structural Features of Lipopolysaccharides and Their Relevance for Economically Important Diseases , 2014, Marine drugs.
[13] C. de Castro,et al. Vibrio vulnificus MO6-24/O Lipopolysaccharide Stimulates Superoxide Anion, Thromboxane B2, Matrix Metalloproteinase-9, Cytokine and Chemokine Release by Rat Brain Microglia in Vitro , 2014, Marine drugs.
[14] L. Bláha,et al. The isolation and characterization of lipopolysaccharides from Microcystis aeruginosa, a prominent toxic water bloom forming cyanobacteria. , 2013, Toxicon : official journal of the International Society on Toxinology.
[15] I. Bechmann,et al. The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas , 2013, Clinical & developmental immunology.
[16] R. Nau,et al. Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells , 2013, Journal of Neuroinflammation.
[17] V. Perry,et al. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration , 2013, Seminars in Immunopathology.
[18] Y. Pang,et al. Intracerebral lipopolysaccharide induces neuroinflammatory change and augmented brain injury in growth-restricted neonatal rats , 2012, Pediatric Research.
[19] Joshua A. Smith,et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.
[20] Claire E. Geddes,et al. Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats , 2011, Journal of Neuroinflammation.
[21] K. Glaser,et al. Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B₂, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[22] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[23] S. Wood,et al. First report of saxitoxin production by a species of the freshwater benthic cyanobacterium, Scytonema Agardh. , 2011, Toxicon : official journal of the International Society on Toxinology.
[24] R. Alizadeh,et al. Extraction, Purification and Characterization of Lipopolysaccharide from Escherichia coli and Salmonella typhi , 2011, Avicenna journal of medical biotechnology.
[25] D. Lantvit,et al. Scytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii. , 2010, Journal of natural products.
[26] C. Colton,et al. Assessing activation states in microglia. , 2010, CNS & neurological disorders drug targets.
[27] G. Luheshi,et al. Leptin modulates cell morphology and cytokine release in microglia , 2010, Brain, Behavior, and Immunity.
[28] Jeak Ling Ding,et al. Endotoxin detection--from limulus amebocyte lysate to recombinant factor C. , 2010, Sub-cellular biochemistry.
[29] S. Franzblau,et al. An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. , 2009, Journal of natural products.
[30] C. Colton. Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.
[31] Sang-H Choi,et al. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.
[32] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[33] Jessica L. Teeling,et al. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms , 2009, Neuroscience.
[34] B. Jin,et al. Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo , 2007, Experimental & Molecular Medicine.
[35] F. Crews,et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.
[36] T. Kielian,et al. Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs) , 2007, Journal of Neuroinflammation.
[37] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[38] Ian Stewart,et al. Cyanobacterial lipopolysaccharides and human health – a review , 2006, Environmental health : a global access science source.
[39] S. Pflugmacher,et al. Ecotoxicological effects of selected cyanobacterial secondary metabolites: a short review. , 2005, Toxicology and applied pharmacology.
[40] M. Cheeran,et al. Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.
[41] M. Caroff,et al. Structure of bacterial lipopolysaccharides. , 2003, Carbohydrate research.
[42] S. Kyrylenko,et al. Regulation of microglial inflammatory response by histone deacetylase inhibitors , 2003, Journal of neurochemistry.
[43] L. Pannell,et al. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. , 2003, Biochemistry.
[44] H. Kettenmann,et al. Interferon‐γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide‐ and pneumococcal cell wall‐stimulated mouse microglia and macrophages , 2002 .
[45] K. Kataoka,et al. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide , 1999, Neuroscience Research.
[46] R. Simone,et al. Opposite effects of interferon‐γ and prostaglandin E2 on tumor necrosis factor and interleukin‐10 production in microglia: A regulatory loop controlling microglia pro‐ and anti‐inflammatory activities , 1999, Journal of neuroscience research.
[47] F. Shi,et al. Neutralization of Macrophage Inflammatory Protein 2 (MIP-2) and MIP-1α Attenuates Neutrophil Recruitment in the Central Nervous System during Experimental Bacterial Meningitis , 1999, Infection and Immunity.
[48] K. Glaser,et al. Escherichia coli lipopolysaccharide potentiation and inhibition of rat neonatal microglia superoxide anion generation: correlation with prior lactic dehydrogenase, nitric oxide, tumor necrosis factor-alpha, thromboxane B2, and metalloprotease release. , 1999, Shock.
[49] J. Whitaker,et al. Expression of chemokine genes in rat glial cells: The effect of myelin basic protein‐reactive encephalitogenic T cells , 1997, Journal of neuroscience research.
[50] T. Molitor,et al. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. , 1997, The Journal of infectious diseases.
[51] R R Schumann,et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. , 1996, Current topics in microbiology and immunology.
[52] U. Ikeda,et al. Expression of cytokine-induced neutrophil chemoattractant in rat cardiac myocytes. , 1995, Journal of molecular and cellular cardiology.
[53] G. Patterson,et al. Scytophycin production by axenic cultures of the cyanobacterium Scytonema ocellatum. , 1994, Natural toxins.
[54] S. Carmeli,et al. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.
[55] H. Flad,et al. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells , 1991, Infection and immunity.
[56] S. Carmeli,et al. Tolytoxin and new scytophycins from three species of Scytonema. , 1990, Journal of natural products.
[57] S. Sk. Endotoxin detection and elimination in biotechnology. , 1986 .
[58] S. Sharma,et al. Endotoxin detection and elimination in biotechnology. , 1986, Biotechnology and applied biochemistry.
[59] G. Kessler,et al. The automated determination of NAD-coupled enzymes. II. Serum lactate dehydrogenase. , 1966, Clinical chemistry.